Takeda Pharmaceuticals Europe Limited

Home page	http://www.takeda.eu/
Business	Operations European Sales & Marketing
Key Products	Pioglitazone Hydrocholoride for the treatment of diabetes Lansoprazole for the treatment of peptic ulcers Leuprolide Acetate for the treatment of prostate cancer and endometriosis Candesartan Cilexetil for the treatment of hypertension
Address	61 Aldwych, London, WC2B 4AE, UK
Telephone	+44- (0)- 203- 116- 8000
Facsimile	+44- (0)- 203- 116- 8001
Founded	2006

Takeda Pharmaceuticals Europe, trading as Takeda Pharmaceuticals Europe Limited, was established in 2006.

The company is based in London and provides strategic direction and management support for its many subsidiaries across Europe:

• • Austria - Takeda Pharma Ges.m.b.H
• • Benelux (Belgium, Netherlands and Luxembourg) - Takeda Pharmaceuticals Benelux bvba
• • France - Laboratoires Takeda
• • Germany - Takeda Pharma GmbH
• • Ireland - Takeda Ireland Limited
• • Italy -Takeda Italia Farmaceutici S.p.A.
• • Nordics (Norway, Denmark, Sweden, Finland and Iceland) -Takeda Pharmaceuticals Nordics AB
• • Portugal - Takeda Farmacêuticos Portugal, Unipessoal, Lda
• • Spain - Takeda Farmacéutica España S.A.U
• • Switzerland - Takeda Pharma AG
• • Turkey - Takeda Ilaçlari Tic. Ltd.Şti
• • United Kingdom - Takeda UK LTD

[*]The information presented at each company's website is governed by laws and regulations of that particular country, and therefore is intended for residents in that country only.